During your visit to BH Cellular Medicine, you will be escorted to a comfortable, private room. The doctors will discuss your upcoming procedure and treatment plan and answer any questions you may have. Our nurses will check your vital signs and take care of you throughout your time at our clinic. The in-and-out procedure takes approximately four hours. Most of this time will be spent relaxing, listening to music or watching television, while Dr. Bertolotto works in the laboratory to prepare your cells for your procedure. The procedure is a minimally invasive, mini liposuction performed under sterile conditions under local anesthesia. The ImPS™ cells will be injected intravenously.
301 N. Canon Drive, Suite 305
Beverly Hills, California 90210
© 2026 | BH Cellular Medicine | All Rights Reserved. All content and images are property of Cristina Bertolotto, MD and cannot be saved or duplicated without expressed written consent.
DISCLAIMER: The information provided on this website is for general educational purposes only and is not medical advice. Any references to cellular or regenerative approaches describe areas of ongoing scientific and clinical research. Except where specifically identified as an FDA‑approved product, the cellular procedures discussed on this website have not been evaluated or approved by the US Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or condition. FDA has stated that stem cell products and products derived from adipose tissue of the type described here have not been approved to treat orthopedic, neurologic, cardiopulmonary, autoimmune, or other chronic conditions.(fda.gov)
Any cellular procedure carries potential risks, and benefits are uncertain. Decisions about care should be made in consultation with a licensed healthcare professional who can review all conventional and investigational options. BH Cellular Medicine endeavors to operate in compliance with applicable US laws and regulations governing human cells, tissues, and cellular and tissue‑based products (HCT/Ps), including requirements under section 361 of the Public Health Service Act and 21 CFR Part 1271, where applicable.(fda.gov)
PHOTO CITATION: Image source: Nature Reviews Endocrinology, March 2010 issue. File name: “NATURE-ENDOCRINOLGY-BH-CELLULAR-1920px.png”.
